Talking Sleep A Guide to OSA Endotyping
Nov 22, 2024
Dr. Danny J. Eckert, a leading sleep and respiratory physiologist and director at the Adelaide Institute for Sleep Health, discusses his groundbreaking work on OSA endotyping. He reveals that 70% of OSA patients suffer from non-anatomical causes, stressing the need for tailored treatment approaches. The chat covers innovative methodologies for assessing airway collapse and explores the significant impact of nasal obstruction on sleep quality. Eckert also highlights the potential of non-PAP treatments and new biomarkers for an improved understanding and management of obstructive sleep apnea.
AI Snips
Chapters
Books
Transcript
Episode notes
OSA Endotypes Enable Precision Care
- Current OSA treatment often fails many patients due to a one-size-fits-all approach.
- Understanding different endotypes allows for more targeted and effective therapies.
Non-Anatomical Causes in OSA
- About 70% of OSA patients have one or more non-anatomical causes.
- These non-anatomical factors can explain poor response to conventional treatments targeting anatomy alone.
PALM: Four Key OSA Traits
- The PALM classification breaks OSA into four mechanistic traits: Pcrit, Arousal threshold, Loop gain, and Muscle response.
- Most OSA patients have issues in one or more of these non-anatomical areas.
